SCHEMBL4192576

SCHEMBL4192576

Cc1ccc(S(=O)(=O)/N=C(\N)Nc2ccccc2CNC(C)CC2CCCCC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.43
PKM P14618 1/20 0.43
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HPGD P15428 1/20 0.42
CTSD P07339 6/20 0.39
PLAU P00749 1/20 0.38
HPN P05981 1/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
F2 P00734 4/20 0.36
PRSS1 P07477 4/20 0.36
PRSS2 P07478 4/20 0.36
PRSS3 P35030 4/20 0.36
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4192581 1.00 KDM4E (0.43) KDM4EPKMALDH1A1LMNASMN1; SMN2
SCHEMBL4203651 0.92 LMNA (0.38) KDM4EPKMALDH1A1LMNACTSD
SCHEMBL4203657 0.92 LMNA (0.38) KDM4EPKMALDH1A1LMNACTSD
SCHEMBL4190882 0.87 CTSD (0.39) KDM4EPKMCTSDKMT2AGRIN2D
SCHEMBL4190888 0.87 CTSD (0.39) KDM4EPKMCTSDKMT2AGRIN2D
SCHEMBL4195029 0.84 F2 (0.40) PKMALDH1A1LMNASMN1; SMN2CTSD
SCHEMBL4195026 0.84 F2 (0.40) PKMALDH1A1LMNASMN1; SMN2CTSD
SCHEMBL4190720 0.81 KDM4E (0.49) KDM4EPKMALDH1A1LMNAPLAU
SCHEMBL4192548 0.78 KMT2A (0.47) KDM4EALDH1A1SMN1; SMN2HPGDKMT2A
SCHEMBL4190300 0.77 PKM (0.49) KDM4EPKMALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885ALDH1A1 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.